Surgery Partners Inc (SGRY) was Initiated by KeyBanc Capital Mkts to “Overweight” and the brokerage firm has set the Price Target at $21. KeyBanc Capital Mkts advised their investors in a research report released on Jun 10, 2016.
Many Wall Street Analysts have commented on Surgery Partners Inc. Shares were Reiterated by RBC Capital Mkts on Mar 14, 2016 to “Outperform” and Lowered the Price Target to $ 20 from a previous price target of $22 .
On the company’s financial health, Surgery Partners Inc reported $-0.15 EPS for the quarter, missing the analyst consensus estimate by $ -0.20 based on the information available during the earnings call on May 5, 2016. Analyst had a consensus of $0.05. The company had revenue of $267.10 million for the quarter, compared to analysts expectations of $254.23 million. The company’s revenue was up 19.2% compared to the same quarter last year.
In a different news, on Oct 23, 2015, Michael Thomas Doyle (Chief Executive Officer) sold 152,966 shares at $19.00 per share price.
Surgery Partners Inc. is a healthcare services company. The Company has differentiated outpatient delivery model focused on providing solutions for surgical and related ancillary care in support of its patients and physicians. It operates through three segments: Surgical Facility Services segment Ancillary Services segment and Optical Services segment. The Surgical Facility Services segment consists of the operation of ASCs and surgical hospitals and includes its anesthesia services. The Ancillary Services Segment consists of a diagnostic laboratory a specialty pharmacy and multi-specialty physician practices. The Optical Services Segment consists of an optical laboratory an optical products group purchasing organization and a marketing business. As of August 17 2015 the Company owned or operated primarily in partnership with physicians a portfolio of 99 surgical facilities which consist of 94 ambulatory surgery centers (ASCs) and five surgical hospitals across 28 states.